Probiotics and prebiotics in primary care for colon cancer;Probióticos e prebióticos na atenção primária ao câncer de cólon

Arquivos de Gastroenterologia

Volumn 47, Issue 1, 2010, Pages 93-98

  Denipote, Fabiana Gouveia ^a   Trindade, Erasmo Benício Santos De Moraes ^b   Burini, Roberto Carlos ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Colonic neoplasms; Prebiotics; Probiotics; Simbiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

CANCER DIAGNOSIS; CANCER PREVENTION; CARCINOGENESIS; COLON CANCER; DRUG USE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; INTESTINE FLORA; PRIMARY MEDICAL CARE; REVIEW;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HUMANS; PREBIOTICS; PROBIOTICS;

EID: 77953182111     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032010000100016     Document Type: Review

References (62)

1. Alexander M. Microbial ecology. New York: John Wiley; 1971.
2. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998;42:2-7.
3. Bengmark S, Lorenzo AG, Culebras MJ. Use of pro, pre and symbiotics in the ICU-future options. Nutr Hosp. 2001;16:239-256
4. Berg R. The indigenous gastrointestinal microflora. Trends microbiol. 1996;4:430-435
5. Bielecka M, Biedrzycka E, Majkowska A. Selection of probiotics and prebiotics for synbiotics and confirmation of their in vivo effectiveness. Food Res Int. 2002;35:125-131 (Pubitemid 34161551)
6. Blaut M. Relationship of probiotics and food to intestinal microflora. Eur J Nutr. 2002;41:11-16 (Pubitemid 36070127)
7. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the danone symposium "The intelligent intestine". Am J Clin Nutr. 2003;78:675-683
8. Burigo T, Fagundes RLM, Trindade EBSM, Vasconcelos HCFF. Efeito bifidogênico do frutooligossacarídeo na microbiota intestinal de pacientes com neoplasia hematológica. Rev Nutr. 2007;20:491-497 (Pubitemid 350232495)
9. Burigo T, Fagundes RLM, Trindade EBSM, Vasconcelos HCFF, Massaut IHB, Rotolo MAS. Ação do prebiótico sobre as proteínas de fase aguda de pacientes com neoplasia hematológica. Rev Bras Hematol Hemoter. 2007;29:130-135
10. Burns AJ, Rowland IR. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol. 2002;1:13-24.
11. Charterisis WP, Kelly PM, Morelli L, Collins JK. Ingredient selection criteria for probiotic microorganisms in functional dairy foods. Int J Dairy Technol. 1998;51:123-136 (Pubitemid 128491110)
12. Cummings JH, Macfarlane GT. Gastrointestinal effects of prebiotics. Br J Nutr. 2002;87:145-151
13. Daly JM, Hoffman K, Lieberman M, Leon P, Redmond HP, Shou J, Torosian MH. Nutritional support in the cancer patient. JPEN J Parenter Enteral Nutr. 1990;14(suppl 5):244s-8s.
14. de Moreno de LeBlanc A, Perdigon G. Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell. 2005;29:15-24. (Pubitemid 40695350)
15. Delia P, Sansotta G, Donato V, Frosina P, Messina G, De Renzis C, Famularo G. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 2007;13:912-915 (Pubitemid 46470303)
16. Fuller R. Probiotics in human medicine. Gut. 1991;32:439-442
17. Gaudier E, Michel C, Segain JP, Cherbut C, Hoebler C. The VSL#3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. J Nutr. 2005;135:2753-2761 (Pubitemid 43156537)
18. Gibson GR, Roberfroid MB. Dietary modulation of human colonic microbiota: introducing the concept of the prebiotics. J Nutr. 1995;125:1401-1412
19. Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr. 1999;129:1438s-41s.
20. Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005;10:40-48 (Pubitemid 43152729)
21. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst. 1980;64:255-261 (Pubitemid 10174170)
22. Guarner E, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519
23. Hart AL, Stagg AJ, Frame M, Graffner H, Glise H, Falk P, Kamm MA. The role of the gut flora in health and disease, and its modification as therapy. Aliment Pharmacol Ther. 2002;16:1383-1393 (Pubitemid 34953580)
24. Havena ARR, Huis in't Veld JHK. Probiotics: a general view. In: Wood B, editor. The lactic acid bacteria in health and disease. London: Elsevier Applied Science; 1992. p.209-224
25. Hayatsu H, Hayatsu T. Supressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 1993;73:173-179 (Pubitemid 23322297)
26. Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000;2:681-686 (Pubitemid 30412579)
27. Holzapfel WH, Schillinger U. Introduction to pre and probiotics. Food Res Int. 2002;35:109-116
28. Hopkins MJ, MacFarlane GT. Nondisgestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol. 2003;69:1920-1927
29. Hosoda M, Hashimoto H, He F, Morita H, Hosono A. Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenecity and microflora in the human intestine. J Dairy Sci. 1996;79:745-749 (Pubitemid 126429105)
30. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med. 2004;229:586-597
31. Instituto Nacional do Câncer. Estimativa 2008: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2007. Disponível em: http://www.inca.gov.br/estimativa/2008/index.aps?link=conteudo-view.asp&ID= 1.
32. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, Ishiguro S, Miyaoka E, Sobue T, Kakizoe T. Randomized trial of dietary fibre and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005;116:762-767 (Pubitemid 41099707)
33. Isolauri E. Probiotics for infectious diarrhea. Gut. 2003; 52:436-437
34. Isolauri E, Salminen S, Ouwehand AC. Probiotics. Best Pract Res Clin Gastroenterol. 2004;8:299-313.
35. Karkow FJA, Faintuch J, Karkow AGM. Probióticos: perspectives médicas. Rev AMRIGS. 2007;51:38-48.
36. Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. J Biosci. 2002;27:703-714 (Pubitemid 36091305)
37. Lidbeck A, Geitner Allinger U, Orrhage KM, Ottova L, Brismar B, Gustafsson JA, Rafter JJ, Nord CE. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microbiol Ecol Health Dis. 1991;4:81-88
38. Lidbeck A, Nord CE, Gustafsson JA, Rafter JJ. Lactobacilli anticarcinogenic activities and human intestinal microflora. Eur J Cancer Prev. 1992;1:341-353
39. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by micro-organisms. Science. 1965;147:747-748
40. Mattila-Sandholm T, Myllärinen P, Crittenden R, Mogensen G, Fondén R, Saarela M. Technological challenges for future probiotic foods. Int Dairy J. 2002;12:173-182 (Pubitemid 34234391)
41. Metchnikoff E. The prolongation of life. London: Heinemann; 1907.
42. O'Mabony L, Feeney M, O'Halloran S, Murphy L, Kiely B, Fitzgibbon J, Lee G, O'Sullivan G, Shanahan F, Collins JK. Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice. Aliment Pharmacol Ther. 2001;15:1219-1225 (Pubitemid 32675457)
43. Orrhage K, Sillerstrom E, Gustafsson JA, Nord C, Rafter JJ. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res. 1994;311:239-248 (Pubitemid 24357450)
44. Passos LML, Park YK. Frutooligossacarídeos: implicaçõ es na saúde humana e utilização em alimentos. Cienc Rural. 2003;33:385-390
45. Peris GP, Lesmes B, Cuerda CM, Alvarez C. Metabolismo colônico de la fibra. Nutr Hosp. 2002;17:11-16
46. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles Country, California. Cancer Causes Control. 1992;3:457-473
47. Rafter J. The role of lactic acid bacteria in colon cancer prevention. Scand J Gastroenterol. 1995;30:497-502.
48. Rafter J. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol. 2003;17:849-859
49. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins JK. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007:85:488-496 (Pubitemid 46220953)
50. Roberfroid MB. Functional food concept and its application to prebiotics. Dig Liver Dis. 2002;34:s105-s10.
51. Rowland IR, Grasso P. Degradation of N-nitrosamines by intestinal bacteria. Appl Microbiol. 1975;29:7-12.
52. Rowland IR, Bearne CA, Fisher R, Pool-Zobel BL. The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats. Nutr Cancer. 1996;26:37-47.
53. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 1998;19:281-285
54. Salminen E, Eloma AI, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol. 1988;39:43-57.
55. Sanders ME. Probiotics: considerations for human health. Nutr Rev. 2003;61:91-99
56. Schrezenmeir J, Vrese M. Probiotics, prebiotics, and synbiotics- approaching a definition. Am J Clin Nutr. 2001;73:s361-s4.
57. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998;52:899-907. (Pubitemid 29008371)
58. Suchner U, Senftleben U, Eckart T, Sholz MR, Beck K, Murr R, Enzenbach R, Peter K. Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism. Nutrition. 1996;12:13-22. (Pubitemid 26082749)
59. Watzl B, Girrbacch S, Roller M. Inulin, oligofructose and immunomodulation. Br J Nutr. 2005;93:49-55.
60. a ed. São Paulo: Cengage Learning; 2008.
61. Young TB, Wolf DA. Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer. 1988;42:167-175
62. Yun J W. Fructooligosaccharides - Occurrence, preparation and applications. Enzyme Microb Technol. 1996;19:107-117